Genes downregulated by both agents included those corresponding to stem cell signatures, SMARCA4 target genes, EMT, and MYC targets, tumor invasiveness and TGFB1 signatures (Fig 6C–D, Extended Data Fig. 6D-E). The gene discussed is MYC; the disease is neoplasm.